Significant Competition definition
Significant Competition means competition or potential competition to the Product from a third party’s product which, notwithstanding the fact that it does not breach any Project Patent:
Significant Competition shall be deemed to exist if, after the introduction in such country of a pharmaceutical product approved by the FDA as a generic drug referenced to Product, for use as a subdermal delivery of buprenorphine, for the treatment of opioid dependence or chronic pain, for a period of three (3) months or longer following a single treatment procedure, aggregate Net Sales of Product in any two (2) consecutive Calendar Quarters is at least [***] less than aggregate Net Sales in the two (2) consecutive Calendar Quarters completed immediately prior to such introduction; or
Significant Competition means that Competing Product(s) sold [***], when taken together, account(s) for [***], as determined by reference to data published in IMS, or such other publication as the JSC may agree, provided that a [***] not constitute a Competing Product for the purposes of Significant Competition.
Examples of Significant Competition in a sentence
Where in any country the Product is subject to Significant Competition, then the rate of royalty payable on Net Sales within that country shall be [***] percent [***] of those rates indicated in Clause 17.1.
Business -- Patents and Proprietary Information." Significant Competition.
More Definitions of Significant Competition
Significant Competition means on a country-per-country and PRODUCT-per-PRODUCT basis including COMBINATIONS, the presence of a competitor other than the second CO-EXCLUSIVE licensee or CPG (or other non exclusive licensees in case of HIV) on such market who is selling a competing product which utilizes unmethylated cytosine guanine dinucleotides as adjuvant in combination with LICENSED ANTIGENS CO-EXCLUSIVELY licensed hereunder, to the extent such competitor obtained a market share of [******] percent ([**]%) or more or has doubled its market share in the previous year from a base market share of at least [****] percent ([*]%).
Significant Competition means competition or potential competition to the Product from a third party’s product which, notwithstanding the fact that it does not breach any Licensed Patent:
Significant Competition with respect to each Licensed Product in each country for each calendar year shall mean that a third party sells a vaccine which competes with a Licensed Product as a given indication, whether in single antigen or multivalent form and such The information below marked by [****] has been omitted pursuant to a request for Confidential Treatment. The omitted portion has been separately filed with the Commission. third party vaccine has a commercially recognized advantage in safety, immunogenicity and/or therapeutic value over the competing Licensed Product and that such third party vaccine [****] of vaccines for the indication concerned. The sale of a Co-Exclusive Vaccine by a licensee of VRI shall not be a third party vaccine for the purpose of this definition.
Significant Competition means on a country-per-country and PRODUCT-per-PRODUCT basis including COMBINATIONS, the marketing by a THIRD PARTY (other than ▇▇▇▇▇ or its other non-exclusive licensee(s)) of a competing product (including a combination) in the FIELD which utilizes unmethylated cytosine guanine dinucleotides as adjuvant in combination with LICENSED ANTIGEN(S) licensed hereunder, to the extent such competitor has achieved a market share of [******] percent ([**]%) or more or has doubled the market share it had achieved in the previous year from a base market share of at least [****] percent.
Significant Competition with respect to each Licensed Product in each country for each calendar year shall mean that a third party sells a mucosally delivered vaccine which competes with a Licensed Product as to a given indication, whether in single antigen or multivalent form and such third party vaccine has a commercially recognized advantage in safety, immunogenicity and/or therapeutic value over the competing Licensed The information below marked by [****] has been omitted pursuant to a request for Confidential Treatment. The omitted portion has been separately filed with the Commission. Product and that such third party vaccine has [****] vaccines for the indication concerned. The sale of a Co-Exclusive Vaccine by a licensee of VRI or the sale of a polyphosphazene adjuvanted parenteral vaccine shall not be a third party vaccine for the purpose of this definition.